(Q50504964)

14 March 2018

title

Intratympanic gentamicin in Meniere's disease. (English)

1 reference

14 March 2018

0 references

Kaasinen S

1

1 reference

14 March 2018

Pyykkö I

series ordinal

2

1 reference

14 March 2018

Ishizaki H

series ordinal

3

1 reference

14 March 2018

Aalto H

series ordinal

4

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

14 March 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oto-Laryngologica

1 reference

14 March 2018

volume

118

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

294-298

1 reference

14 March 2018

Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00016489850183359

The influence of elective neck dissection on neck relapse in NO supraglottic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016489850183359

Intratympanic gentamycin in severe Ménière's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016489850183359

Intratympanic gentamicin in bilateral Menière's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016489850183359

Effects of Systemic and Lateral Semicircular Canal Administration of Aminoglycosides on Normal and Hydropic Inner Ears

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016489850183359

10.1080/00016489850183359

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018